The DNA damage response: A common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells

Frontiers in Immunology

Volumn 4, Issue JAN, 2014, Pages

  Cerboni, Cristina ^a   Fionda, Cinzia ^a   Soriani, Alessandra ^a   Zingoni, Alessandra ^a   Doria, Margherita ^b   Cippitelli, Marco ^a   Santoni, Angela ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c Neurological Mediterranean Institute   (Italy)

Author keywords

DNA damage response; DNAM 1 ligands; NK cells; NKG2D ligands; Stress

Indexed keywords

ATM PROTEIN; ATR PROTEIN; DNAM 1 RECEPTOR; MEMBRANE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN P53; STAT3 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL PROLIFERATION; CELLULAR STRESS SIGNAL; DNA DAMAGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 84987776130     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00508     Document Type: Short Survey

References (77)

1. 2D ligand expression on host immune responses. Immunol Rev (2010) 235(1):267-85. doi: 10.1111/j.0105-2896.2010.00893.x
2. Gleimer M, Parham P. Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity (2003) 19(4):469-77. doi:10.1016/S1074-7613(03)00272-3
3. 2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses. Front Immunol (2012) 3:408. doi:10.3389/fimmu.2012.00408
4. Baychelier F, Vieillard V. The modulation of the cell-cycle: a sentinel to alert the NK cells of dangers. Front Immunol (2013) 4:325. doi:10.3389/fimmu.2013.00325
5. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity (1996) 4(6):573-81. doi:10.1016/S1074-7613(00)70060-4
6. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med (2003) 198(4):557-67. doi:10.1084/jem.20030788
7. 2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood (2009) 113(15):3503-11. doi:10.1182/blood-2008-08-173914
8. Ardolino M, Zingoni A, Cerboni C, Cecere F, Soriani A, Iannitto ML, et al. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Blood (2011) 117(18):4778-86. doi:10.1182/blood-2010-08-300954
9. 2D and DNAM-1 systems. Anticancer Res (2012) 32(6):2241-7.
10. Iannello A, Raulet DH. Immune surveillance of unhealthy cells by natural killer cells. Cold Spring Harb Symp Quant Biol (2013). doi:10.1101/sqb.2013.78.020255
11. 2D receptor. Nature (2005) 436(7054):1186-90. doi:10.1038/nature03884
12. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell (2010) 40(2):179-204. doi:10.1016/j.molcel.2010.09.019
13. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 73:39-85. doi:10.1146/annurev.biochem.73.011303.073723
14. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature (2009) 461(7267):1071-8. doi:10.1038/nature08467
15. Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature (2012) 481(7381):287-94. doi:10.1038/nature10760
16. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature (2004) 432(7015):316-23. doi:10.1038/nature03097
17. Derheimer FA, Kastan MB. Multiple roles of ATM in monitoring and maintaining DNA integrity. FEBS Lett (2010) 584(17):3675-81. doi:10.1016/j.febslet.2010.05.031
18. Lovejoy CA, Cortez D. Common mechanisms of PIKK regulation. DNA Repair (Amst) (2009) 8(9):1004-8. doi:10.1016/j.dnarep.2009.04.006
19. Oricchio E, Saladino C, Iacovelli S, Soddu S, Cundari E. ATM. Cell Cycle (2006) 5(1):88-92. doi:10.4161/cc.5.1.2269
20. Yang DQ, Kastan MB. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol (2000) 2(12):893-8. doi:10.1038/35046542
21. Bredemeyer AL, Sharma GG, Huang CY, Helmink BA, Walker LM, Khor KC, et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature (2006) 442(7101):466-70. doi:10.1038/nature04866
22. 2AX. Science (2000) 290(5498):1962-5. doi:10.1126/science.290.5498.1962
23. 2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol (2010) 184(12):6901-9. doi:10.4049/jimmunol.0903985
24. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature (2004) 431(7011):997-1002. doi:10.1038/nature02989
25. Fukao T, Kaneko H, Birrell G, Gatei M, Tashita H, Yoshida T, et al. ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells. Blood (1999) 94(6):1998-2006.
26. 2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes. Cell Prolif (2007) 40(1):1-13. doi:10.1111/j.1365-2184.2007.00417.x
27. 2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood (2007) 110(2):606-15. doi:10.1182/blood-2006-10-052720
28. 2D ligands released by activated T cells. Blood (2009) 113(13):2955-64. doi:10.1182/blood-2008-06-165944
29. 2D, LFA-1 and TRAIL and dampened via CD94/NKG2A. PLoS One (2012) 7(2):e31959. doi:10.1371/journal.pone.0031959
30. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A (1996) 93(22):12445-50. doi:10.1073/pnas.93.22.12445
31. 2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A (2003) 100(16):9452-7. doi:10.1073/pnas.1632807100
32. Zou Y, Mirbaha F, Stastny P. Contact inhibition causes strong downregulation of expression of MICA in human fibroblasts and decreased NK cell killing. Hum Immunol (2006) 67(3):183-7. doi:10.1016/j.humimm.2006.02.018
33. Erickson BM, Thompson NL, Hixson DC. Tightly regulated induction of the adhesion molecule necl-5/CD155 during rat liver regeneration and acute liver injury. Hepatology (2006) 43(2):325-34. doi:10.1002/hep.21021
34. 2D activity by regulating MICA expression and shedding. J Innate Immun (2013) 6(1):89-104. doi:10.1159/000351605
35. 2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol (2005) 6(9):938-45. doi:10.1038/ni1236
36. Molinero LL, Fuertes MB, Girart MV, Fainboim L, Rabinovich GA, Costas MA, et al. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol (2004) 173(9):5583-90.
37. 2D. J Immunol (2007) 178(2):961-9.
38. 2D receptor are regulated by E2F transcription factors, which control cell cycle entry. J Exp Med (2012) 209(13):2409-22. doi:10.1084/jem.20120565
39. Nolte-'t Hoen EN, Almeida CR, Cohen NR, Nedvetzki S, Yarwood H, Davis DM. Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication. Blood (2007) 109(2):670-3. doi:10.1182/blood-2006-07-036509
40. Sinclair A, Yarranton S, Schelcher C. DNA-damage response pathways triggered by viral replication. Expert Rev Mol Med (2006) 8(5):1-11. doi:10.1017/S1462399406010544
41. Lilley CE, Schwartz RA, Weitzman MD. Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol (2007) 15(3):119-26. doi:10.1016/j.tim.2007.01.003
42. Turnell AS, Grand RJ. DNA viruses and the cellular DNA-damage response. J Gen Virol (2012) 93(Pt 10):2076-97. doi:10.1099/vir.0.044412-0
43. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol (2008) 8(4):259-68. doi:10.1038/nri2276
44. Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, Aicheler R, et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol (2008) 41(3):206-12. doi:10.1016/j.jcv.2007.10.027
45. 2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol (2007) 88(Pt 1):242-50. doi:10.1099/vir.0.82125-0
46. -1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog (2009) 5(10):e1000613. doi:10.1371/journal.ppat.1000613
47. 2D receptor and promotes NK cell-mediated killing. Blood (2010) 115(7):1354-63. doi:10.1182/blood-2009-08-237370
48. Matusali G, Potesta M, Santoni A, Cerboni C, Doria M. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol (2012) 86(8):4496-504. doi:10.1128/JVI.05788-11
49. 2D expression and cytotoxicity of NK cells. FASEB J (2013) 27(6):2440-50. doi:10.1096/fj.12-223057
50. Vassena L, Giuliani E, Matusali G, Cohen E, Doria M. The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway. J Gen Virol (2013) 94(Pt 12):2664-9. doi:10.1099/vir.0.055541-0
51. Le RE, Belaidouni N, Estrabaud E, Morel M, Rain JC, Transy C, et al. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle (2007) 6(2):182-8. doi:10.4161/cc.6.2.3732
52. -1 Vpr: mechanisms of G2 arrest and apoptosis. Exp Mol Pathol (2008) 85(1):2-10. doi:10.1016/j.yexmp.2008.03.015
53. -1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog (2007) 3(7):e85. doi:10.1371/journal.ppat.0030085
54. Norman JM, Mashiba M, McNamara LA, Onafuwa-Nuga A, Chiari-Fort E, Shen W, et al. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol (2011) 12(10):975-83. doi:10.1038/ni.2087
55. -1 infection by a small molecule inhibitor of the ATM kinase. Nat Cell Biol (2005) 7(5):493-500. doi:10.1038/ncb1250
56. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A (2001) 98(20):11521-6. doi:10.1073/pnas.201238598
57. 2D receptor stimulate tumour immunity. Nature (2001) 413(6852):165-71. doi:10.1038/35093109
58. 2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity (2008) 28(4):571-80. doi:10.1016/j.immuni.2008.02.016
59. 2D, a receptor for stress-inducible MICA. Science (1999) 285(5428):727-9. doi:10.1126/science.285.5428.727
60. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A (1999) 96(12):6879-84. doi:10.1073/pnas.96.12.6879
61. 2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol (2001) 31(4):1076-86. doi:10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y
62. Iguchi-Manaka A, Kai H, Yamashita Y, Shibata K, Tahara-Hanaoka S, Honda S, et al. Accelerated tumor growth in mice deficient in DNAM-1 receptor. J Exp Med (2008) 205(13):2959-64. doi:10.1084/jem.20081611
63. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature (2005) 434(7035):864-70. doi:10.1038/nature03482
64. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature (2005) 434(7035):907-13. doi:10.1038/nature03485
65. Jinushi M, Vanneman M, Munshi NC, Tai YT, Prabhala RH, Ritz J, et al. MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc Natl Acad Sci U S A (2008) 105(4):1285-90. doi:10.1073/pnas.0711293105
66. Croxford JL, Tang ML, Pan MF, Huang CW, Kamran N, Phua CM, et al. ATM-dependent spontaneous regression of early Emu-myc-induced murine B-cell leukemia depends on natural killer and T cells. Blood (2013) 121(13):2512-21. doi:10.1182/blood-2012-08-449025
67. 2D receptor by proteasome inhibitors. Cancer Res (2008) 68(5):1546-54. doi:10.1158/0008-5472.CAN-07-2973
68. Tang KF, He CX, Zeng GL, Wu J, Song GB, Shi YS, et al. Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine. Biochem Biophys Res Commun (2008) 370(4):578-83. doi:10.1016/j.bbrc.2008.03.131
69. Tang KF, Ren H, Cao J, Zeng GL, Xie J, Chen M, et al. Decreased dicer expression elicits DNA damage and up-regulation of MICA and MICB. J Cell Biol (2008) 182(2):233-9. doi:10.1083/jcb.200801169
70. 2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis. Clin Sarcoma Res (2012) 2(1):8. doi:10.1186/2045-3329-2-8
71. 2D ligand expression and metastasis in tumors by spironolactone via RXRgamma activation. J Exp Med (2013) 210(12):2675-92. doi:10.1084/jem.20122292
72. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature (2000) 408(6811):433-9. doi:10.1038/35044005
73. 2D ligands ULBP1 and ULBP2. Cancer Res (2011) 71(18):5998-6009. doi:10.1158/0008-5472.CAN-10-3211
74. Li H, Lakshmikanth T, Garofalo C, Enge M, Spinnler C, Anichini A, et al. Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. Cell Cycle (2011) 10(19):3346-58. doi:10.4161/cc.10.19.17630
75. 2D. Cancer Res (2012) 72(2):460-71. doi:10.1158/0008-5472.CAN-11-1977
76. Bedel R, Thiery-Vuillemin A, Grandclement C, Balland J, Remy-Martin JP, Kantelip B, et al. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. Cancer Res (2011) 71(5):1615-26. doi:10.1158/0008-5472.CAN-09-4540
77. 2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of STAT3. J Immunol (2013) 190(12):6662-72. doi:10.4049/jimmunol.1201426